ResMed has a minority stake in Nyxoah who are developing a neurostimulation implant to treat OSA. Although we see little near-term risk from this therapy due to the higher cost and invasive surgery ...

The exterior presents itself with all the fanfare of a building that knows its reputation precedes it – simple block lettering spelling out “MILLER’S CHICKEN” against white-painted brick with red trim ...